Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19
ConclusionIn our study, we also observed the nucleotide sequence of protease protein consisting of 316 amino acid residues and the influence of these pronouncing drugs over these sequences. The outcome of this research work provides researchers with a track record for carrying out further investigational procedures by applying docking simulations and in vitro and in vivo experimentation with these reprofile drugs so that a better drug can be formulated against coronavirus.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Coronavirus | Covid Vaccine | COVID-19 | General Medicine | Infectious Diseases | Ireland Health | Pandemics | Relenza | Respiratory Medicine | SARS | Science | Study | Vaccines | Zanamivir